Mottola Frank

SVP, Chief Tech. Ops. Officer at SUPERNUS PHARMACEUTICALS, INC.

Sold, on record
$2.7M
Dollars the filings state
Form 4 sales
7
Latest Mar 9, 2026
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

1
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice SUPERNUS PHARMACEUTICALS, INC.Notice
    Nov 14, 2023 2023

    Filed to sell 1,110 shares ($31k)

    Mottola Frank, Officer

    No 10b5-1 planFiling

  2. 2 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.No plan
    Nov 14, 2023 same day

    Sold 1,110 shares at $28.13 ($31k)

    Mottola Frank, SVP, Quality, GMP, Ops, IT

    No 10b5-1 planSold 16.3% of holdings ($191k position)5,681 shares leftFollows a Form 144Filing

  3. 3 Form 144 notice SUPERNUS PHARMACEUTICALS, INC.Notice
    Nov 7, 2024 +359 days

    Filed to sell 15,000 shares ($555k)

    Mottola Frank, Officer

    No 10b5-1 planFiling

  4. 4 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Unusual
    Nov 7, 2024 same day

    Sold 15,000 shares at $36.98 ($555k)

    Mottola Frank, SVP, Quality, GMP, Ops, IT

    No 10b5-1 planSold 64.7% of holdings ($858k position)8,200 shares leftFollows a Form 144Filing

  5. 5 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Unusual
    Aug 25, 2025 +291 days

    Sold 14,000 shares at $44.51 ($623k)

    Mottola Frank, SVP, Quality, GMP, Ops, IT

    No 10b5-1 planSold 47.5% of holdings ($1.3M position)15,496 shares leftFiling

  6. 6 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.No plan
    Sep 12, 2025 +18 days

    Sold 5,000 shares at $45.87 ($229k)

    Mottola Frank, SVP, Chief Tech. Ops. Officer

    No 10b5-1 planSold 24.4% of holdings ($940k position)15,496 shares left0.4x usual sizeFiling

  7. 7 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.Routine
    Dec 19, 2025 +98 days

    Sold 20,000 shares at $50.41 ($1M)

    Mottola Frank, SVP, Chief Tech. Ops. Officer

    10b5-1 planSold 56.3% of holdings ($1.8M position)15,496 shares left1.4x usual sizeFiling

  8. 8 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.No plan
    Mar 9, 2026 +80 days

    Sold 1,623 shares at $53.65 ($87k)

    Mottola Frank, SVP, Chief Tech. Ops. Officer

    No 10b5-1 planSold 8.1% of holdings ($1.1M position)18,440 shares left0.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Mottola Frank
Source
Mar 9, 2026Mar 10, 2026SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. OfficerForm 4 sale1,623$87k8.1%No planSEC
Dec 19, 2025Dec 22, 2025SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. OfficerForm 4 sale20,000$1M56.3%RoutineSEC
Sep 12, 2025Sep 15, 2025SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. OfficerForm 4 sale5,000$229k24.4%No planSEC
Aug 25, 2025Aug 27, 2025SUPERNUS PHARMACEUTICALS, INC.SVP, Quality, GMP, Ops, ITForm 4 sale14,000$623k47.5%UnusualSEC
Nov 7, 2024Nov 8, 2024SUPERNUS PHARMACEUTICALS, INC.SVP, Quality, GMP, Ops, ITForm 4 sale15,000$555k64.7%UnusualSEC
Nov 7, 2024Nov 7, 2024SUPERNUS PHARMACEUTICALS, INC.OfficerForm 144 notice15,000$555kNoticeSEC
Nov 14, 2023Nov 16, 2023SUPERNUS PHARMACEUTICALS, INC.SVP, Quality, GMP, Ops, ITForm 4 sale1,110$31k16.3%No planSEC
Nov 14, 2023Nov 14, 2023SUPERNUS PHARMACEUTICALS, INC.OfficerForm 144 notice1,110$31kNoticeSEC
Mar 14, 2023Mar 16, 2023SUPERNUS PHARMACEUTICALS, INC.Sr VP, Quality, GMP Oper. & ITForm 4 sale4,780$172k50.2%UnusualSEC